Stock Rich List
Nasdaq: MNPR

Monopar Therapeutics insiders

The officers, directors and 10% owners of Monopar Therapeutics Inc. who hold the most stock, valued at the live MNPR price.

$70.29
MNPR today −$460K (−0.65%)
Market closed. Prices as of Nov 19, 4:04 PM ET
Ranked insiders
4
Their MNPR stock
$138M
Market value
$476M
Held by ranked insiders
28.9%

Insiders by value of MNPR holdings

SEC ownership page
#InsiderRoleSharesValueOf companyOverall rank
1Andrew Paul MazarChief Scientific Officer860,013$60.5M12.7%2224th
2Diane Hendricks10% owner661,330$46.5M9.76%2676th
3Michael J. BrownInsider272,026$19.1M4.01%1107th
4Chandler RobinsonChief Executive Officer166,942$11.7M2.46%7793rd

Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Monopar Therapeutics; see each profile for the filing.